CRISPR Therapeutics (Germany) Analysis
| 1CG Stock | 40.80 0.00 0.00% |
CRISPR Therapeutics AG is fairly valued with Real Value of 40.8 and Hype Value of 40.8. The main objective of CRISPR Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what CRISPR Therapeutics AG is worth, separate from its market price. There are two main types of CRISPR Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect CRISPR Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of CRISPR Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The CRISPR Therapeutics stock is traded in Germany on Stuttgart Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. CRISPR Therapeutics is usually not traded on GermanUnityDay, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, International Workers ' Day. CRISPR Stock trading window is adjusted to Europe/Berlin timezone.
CRISPR |
CRISPR Therapeutics Investment Alerts
| CRISPR Therapeutics generated a negative expected return over the last 90 days | |
| CRISPR Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 436 K. Net Loss for the year was (650.17 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CRISPR Therapeutics generates negative cash flow from operations |
CRISPR Therapeutics Thematic Classifications
In addition to having CRISPR Therapeutics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ISPInternet Service Providers |
CRISPR Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CRISPR Therapeutics's market, we take the total number of its shares issued and multiply it by CRISPR Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
CRISPR Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.CRISPR Therapeutics Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. CRISPR Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for CRISPR Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
CRISPR Therapeutics Outstanding Bonds
CRISPR Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CRISPR Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CRISPR bonds can be classified according to their maturity, which is the date when CRISPR Therapeutics AG has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding CRISPR Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Additional Tools for CRISPR Stock Analysis
When running CRISPR Therapeutics' price analysis, check to measure CRISPR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CRISPR Therapeutics is operating at the current time. Most of CRISPR Therapeutics' value examination focuses on studying past and present price action to predict the probability of CRISPR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CRISPR Therapeutics' price. Additionally, you may evaluate how the addition of CRISPR Therapeutics to your portfolios can decrease your overall portfolio volatility.